Home > Boards > US Listed > Biotechs > Fluidigm Corp. (FLDM)

We have 27 Days left in Q2, FLDM

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
pkdaddy64 Member Profile
 
Followed By 251
Posts 15,262
Boards Moderated 0
Alias Born 06/12/09
160x600 placeholder
Fluidigm to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 5/14/2021 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/11/2021 4:52:43 PM
Fluidigm gains after report that activist takes 11% stake, may push for unit sale Seeking Alpha - 5/10/2021 9:10:17 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/10/2021 4:31:29 PM
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time GlobeNewswire Inc. - 5/10/2021 1:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2021 5:31:54 PM
Fluidigm EPS misses by $0.11, beats on revenue Seeking Alpha - 5/6/2021 4:31:48 PM
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year P... GlobeNewswire Inc. - 5/6/2021 4:05:00 PM
Data Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies t... GlobeNewswire Inc. - 5/6/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2021 6:32:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/14/2021 5:22:43 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/14/2021 5:15:53 PM
Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results GlobeNewswire Inc. - 4/8/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/25/2021 7:38:02 PM
Fluidigm shares rise 17% on emergency use nod in U.S. for Advanta SARS-CoV test Seeking Alpha - 3/1/2021 8:57:23 AM
FDA Grants Emergency Use Authorization for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay GlobeNewswire Inc. - 3/1/2021 8:30:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2021 2:22:59 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 12:36:44 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 5:16:01 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 12:03:20 PM
Fluidigm inks supply and distribution deal with Zhejiang PuLuoTing Health Seeking Alpha - 2/10/2021 4:18:40 PM
Fluidigm EPS misses by $0.14, misses on revenue Seeking Alpha - 2/10/2021 4:11:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/10/2021 4:10:10 PM
Fluidigm Announces Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire Inc. - 2/10/2021 4:05:00 PM
George Mason University Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platfor... GlobeNewswire Inc. - 2/10/2021 4:02:00 PM
pkdaddy64   Wednesday, 06/03/20 08:40:01 AM
Re: None
Post # of 597 
We have 27 Days left in Q2, FLDM could get Approval at any time.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences